Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash ($8.4 billion). See more Cubist was founded in May 1992 by John K. Clarke, Paul R. Schimmel, Ph.D. and Barry M. Bloom, Ph.D, all of whom were also directors. Cubist appeared on Fortune 2010’s List of fastest growing companies, and was named to … See more The company developed Cubicin (daptomycin) for injection, the first antibiotic in a class of anti-infectives called lipopeptides. In 2011, Cubist settled a patent litigation with Teva Pharmaceutical Industries regarding Cubicin. In April 2011 it reached a deal … See more WebCubist Pharmaceuticals is focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIND (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides.
Cubist pharmaceuticals - Email Address & Phone Number - Lusha
WebOct 24, 2011 · Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in ... WebSep 12, 2013 · Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s web … greenacres testing site
Cubist Pharmaceuticals - CBST Stock Forecast, Price & News
WebCubist Pharmaceuticals was founded in 1992 in Lexington, Massachusetts. They are a pharmaceutical company whose products provide anti-infective and antibiotic treatments and therapies. Having been in business for just over 15 years, Cubist Pharmaceuticals has decided to focus the marketing of their products specifically on the United States. WebCubist Pharmaceuticals · Medical Affairs Connect with experts in your field Join ResearchGate to contact this researcher and connect with your scientific community. … WebMar 23, 2024 · Cubist Pharmaceuticals : meldet FDA-Zulassung seines neuen Antibiotikums ZERBAXA™ (C.. 2014: Cubist Pharmaceuticals : annonce l'approbation par la FDA du nouvel antibiotique ZERBAXA&t.. 2014: Merck & Co acquiert Cubist Pharma pour 8,4 milliards de dollars: 2014: Wall Street ouvre en baisse, l'Asie inquiète: 2014 green acres the coming out party